This study was completed to evaluate the prospective from the CPPs with tumor-focusing on Homes to deliver a cytotoxic payload to HCC cells. We explored employing a CXCR4-focusing on peptide, T22, fused with cytotoxic peptide PE24, being a novel therapeutic technique for CXCR4+ HCC cells. T22 was picked out since https://https-1433116-com08630.angelinsblog.com/30822971/the-best-side-of-https-2212580-com